Biomedical papers - Ahead of Print

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. X:X | 10.5507/bp.2017.048

Comparison of lymphatic vessel density and expression of VEGF-C and VEGF-D lymphangiogenic factors in Warthin's tumours and oncocytic adenomas

Jiri Hozaa, Richard Salzmana, Tomas Bakaja, Ladislava Kucerovab, Ivo Stareka
a Department of Otorhinolaryngology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
b Department of Molecular Pathology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic

Objectives: To compare the density of lymphatic vessels and VEGF-C and VEGF-D expression in Warthin's tumours (WTs) and oncocytic adenomas (OCAs).

Methods: Twenty three WTs and 13 OCAs of the parotid gland were analyzed. Lymphatic vessels were detected using the D2-40 antibody. For evaluation of the intratumour and peritumour lymphatic vessel density (iLVD and pLVD, respectively) the area of greatest vascularisation (hot spots) was chosen, using a ×40 field, and the number of vessels per square millimeter was counted in a ×200 field. The staining intensity for VEGF-C and VEGF-D immunoreaction in the tumour cells was graded from 0 to 3.

Results: The mean iLVD and pLVD values in WTs was 4.7 (range 1-8) and 6.9 (range 3-10), those in the OCAs 1.0 (range 0-3) and 5.8 (range 2-8), respectively. The differences in the iLVD, but not pLVD between the two tumour groups were statistically significant. In both entities, the pLVD markedly outnumbered the iLVD. The intratumour vessels in the WTs were present exclusively in the lymphoid stroma. In the group of 23 WTs, 13 (56.6%), 17 (73.9%) and 10 (43.4%) samples revealed positive VEGF-C, VEGF-D and both immunoreactions, respectively. 10 of 13 (77%) cases revealed VEGF-D immunoreaction and in none of them was the VEGF-C reaction present.

Conclusion: The tumours had a comparable high density of peritumorous lymphatic network. However, WTs markedly differed from OCAs in the number of the intratumorous vessels. These were abundant solely in the stroma of WT, while practically lacking in the neoplastic epithelium of the WT and relatively rare in OCAs. We suggest that homeostasis in both entities is mediated mainly by peritumorous lymphatics. The lymphatic drainage in WTs is also fostered exclusively by stromal lymphatics, whereas in stroma poor OCAs by the vessels present in their neoplastic epithelium. We also believe that WTs stimulate proliferation of pre-existing lymphatic capillaries by means of the paracrine secretion of VEGF-C and VEGF-D in the neoplastic as well as reactive stromal cells, while in the OCAs only the latter factor takes part in their lymphangiogenesis.

Keywords: lymphatic vessel density, oncocytoma, Warthin's tumor, salivary gland

Received: April 5, 2017; Accepted: October 25, 2017; Prepublished online: November 2, 2017


References

  1. Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005;5(9):735-43. Go to original source... Go to PubMed...
  2. Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell 2010;140(4):460-76. Go to original source... Go to PubMed...
  3. Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998;95(2):548-53. Go to original source... Go to PubMed...
  4. Gerwins P, Sköldenberg E, Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors inangiogenesis. Crit Rev Oncol Hematol 2000;34(3):185-94. Go to original source... Go to PubMed...
  5. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996;122(12):3829-37. Go to PubMed...
  6. Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005;7(2):121-7. Go to original source... Go to PubMed...
  7. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005;438(7070):946-53. Go to original source... Go to PubMed...
  8. Audet N, Beasly NJ, MacMillan C, Jackson DG, Gullane PJ, Kamel-Reid S. Lymphatic vessel density, nodal metastasis, and prognosis in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2005;131(12):1065-70. Go to original source... Go to PubMed...
  9. Beasly NJ, Prevo R, Banerji S, Leek RD, Moore J, van Trappen P, Cox G, Harris AL, Jackson DG. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002;62(5):1315-20. Go to PubMed...
  10. Burian M, Quint C, Neuchrist C. Angiogenic factors in laryngeal carcinomas: do they have prognostic relevance?. Acta Otolaryngol 1999;119(2):289-92. Go to original source... Go to PubMed...
  11. Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 2005;18(1):143-52. Go to original source... Go to PubMed...
  12. Hu WG, Li JW, Feng B, Beveridge M, Yue F, Lu AG, Ma JJ, Wang ML, Guo Y, Jin XL, Zheng MH. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Eur Surg Res 2007;39(4):229-38. Go to original source... Go to PubMed...
  13. Inoue K, Ozeki Y, Sugunuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous carcinoma. Cancer 1997;79(2):206-13. Go to original source... Go to PubMed...
  14. Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, Matsutani N, Yasui W, Chayama K. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 2001;93(5):662-6. Go to original source... Go to PubMed...
  15. Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005;206(2):170-7. Go to original source... Go to PubMed...
  16. Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A, Wennerberg J. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 2000;83(6):775-81. Go to original source... Go to PubMed...
  17. Moehler M, Frings C, Muller A, Gockel I, Schimanski CC, Biesterfeld S, Galle PR, Holtmann MH. VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab. World J Gastroenterol 2008;14(26):4156-67. Go to original source... Go to PubMed...
  18. O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001;92(3):556-68. Go to original source... Go to PubMed...
  19. Salven P, Lymboussaki A, Heikkilä P, Jääskela-Saari H, Enholm B, Aase K, von Euler G, Eriksson U, Alitalo K, Joensuu H. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Amer J Pathol 1998;153(1):103-8. Go to original source...
  20. Sedivy R, Beck-Mannagetta J, Haverkampf C, Battistutti W, Hönigschnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 2003;32(8):455-60. Go to original source... Go to PubMed...
  21. Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis - impact on cancer metastasis. J Leukocyt Biol 2006;80(4):691-6. Go to original source... Go to PubMed...
  22. Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K, Koji T. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 1999;80(1-2):309-13. Go to original source... Go to PubMed...
  23. Xuan M, Fang YR, Wato M, Hata S, Tanaka A.Immunohistochemical co-localization of lymphatics and blood vessels in oral squamous cell carcinomas. J Oral Pathol Med 2005;34(6):334-9. Go to original source... Go to PubMed...
  24. Spiro RH, Huvos AG, Strong EW. Cancer of the parotid gland: A clinicopathologic study of 288 primary cases. Am J Surg 1975;130(4):452-9. Go to original source... Go to PubMed...
  25. Mello MF, Costa AF, Freitas LL, Soares AB, Araujo VC, Tincani AJ, Martins AS, Altemani A. Lymphatic vessel density and expressions of lymphangiogenic growth factors in salivary carcinomas. Neoplasma 2011;58(4):331-6. Go to original source... Go to PubMed...
  26. Fujita G, Sato S, Kishino M, Iwai S, Nakazawa M, Toyosawa S, Yura Y, Ogawa Y. Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland. Mod Pathol 2011;24(7):885-91. Go to original source... Go to PubMed...
  27. Starek I, Salzman R, Kučerová L, Skálová A, Hauer L. Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma. Pathol Res Pract 2015;211(10):759-65. Go to original source... Go to PubMed...
  28. Soares AB, Ponchio L, Juliano PB, de Araújo VC, Altemani A. Lymphatic vascular density and lymphagiogenesis during tumor progression of carcinoma ex pleomorphic adenoma. J Clin Pathol 2007;60(9):995-1000. Go to original source... Go to PubMed...
  29. Faur AC, Lazar E, Cornianu M. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumors. APMIS 2014;122(5):418-26. Go to original source... Go to PubMed...
  30. Nakamura Y., Yamamoto M, Sakamoto K, Ohta K, Umeda A, Tsukamoto T, Nakashima T. Growth factors, extracellular matrix components and cell adhesion molecules in Warthin's tumor. J. Oral Pathol Med 2001;30(5):290-5. Go to original source... Go to PubMed...
  31. Swelam W, Ida-Yonemochi H, Maruyama S, Ohshiro K, Cheng J, Saku T. Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma. Virchows Arch 2005;446(6):653-62. Go to original source... Go to PubMed...
  32. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005;201(7):1089-99. Go to original source... Go to PubMed...
  33. Maeda K, Chung Y, Ogawa LY, Kang SM, Ogawa M, Takatsuka S et al. Prognostic value of vascular endothelial factor expression in gastric carcinoma. Cancer 1996;77:858-63. Go to original source... Go to PubMed...
  34. Decaussin M, Sartelet H, Robert C, Moro D. Claralz C, Brmabilla C et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in non small cell lung carcinoma: correlation with angiogenesis and survival. J Pathol 1999;188:369-77. Go to original source... Go to PubMed...
  35. Hwang C, Heath EL. Angiogenesis inhibitors in the treatment of prostate cancer. J Hematol Oncol 2010;3:26. Go to original source... Go to PubMed...
  36. Maeda T, Matsumura S, Hiranuma H, Jikko A, Furukawa S, Ishida T, Fuchihata H. Expression of p53 and vascular endothelial factor in human oral squamous cell carcinoma: Its association with tumor progression and p53 status. J Clin Pathol 1998;51(10):771-5. Go to original source... Go to PubMed...
  37. Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, Hong SP, Lim CY. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, K-67 and prognosis. J Oral Pathol Med 2003;32(9):552-61. Go to PubMed...
  38. Lequerica-Fernández P, Astudillo A, De Vicente JC. Expression of vascular endothelial growth factor in salivary gland carcinoma correlates with lymph node metastasis. Anticancer Res 2007;27:3661-6. Go to PubMed...
  39. Lee SK, Kwon MS, Lee YS, Choi SH, Kim SY, CHo KJ, Nam SY. Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary gland compares with lymph node metastasis: a retrospective study. World J Surg Oncol 2012;10:266-80. Go to original source... Go to PubMed...
  40. Ou Yang K, Liang J, Huang ZQ. Association of clinicopathologic parameters with the expression of inducible nitric oxide synthase and vascular endothelial growth factor in mucoepidermoid carcinoma. Oral Dis 2011;17:590-6. Go to original source... Go to PubMed...
  41. Faur AC, Lazar E, Cornianu M. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumors. APMIS 2013;122:418-26. Go to original source... Go to PubMed...
  42. Pammer J, Weninger W, Mildner M, Burian M, Wojta J, Tschachler E. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol 1998;186(2):186-91. Go to original source... Go to PubMed...
  43. Faria PR, Lima RA, Dias FL, de Faria PAS, Eisenberg ALA, DoNascimento Souza KC, Cardovo SV, Loyola AM. Vascular endothelial growth factor and tymidine phosphorylase expression in salivary gland tumors with distinct metastatic behavior. J Oral Pathol Med 2011;40:456-9. Go to original source... Go to PubMed...
  44. Salzman R, Stárek I, Kučerová L, Skálová A, Hoza J. Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma. Virchows Arch 2014;464:29-34. Go to original source... Go to PubMed...
  45. Soares AB, De Araujo VC, Juliano PB, Altemani A. Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma. J Oral Pathol Med 2009;38(8):623-9. Go to original source... Go to PubMed...
  46. Soares AB, Altemani A, De Oliveira TR, de Oliveira Fonseca Rodrigues F, Ribeiro-Silva A, Soave DF, Passador-Santos F, Brum ST, Napimoga MH, de Araújo VC. Comparison of the blood and lymphatic microvessel density of pleomorphic adenoma and basal cell adenoma. Clin Med Insights Pathol 2015;8:17-21. Go to original source... Go to PubMed...
  47. Teymoortash A, Werner JA. Tissue that has lost its track: Warthin's tumour. Virchows Arch 2005;446(6):585-8. Go to original source... Go to PubMed...
  48. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Gatter KC, Harris AL, Jackson DG. LYVE-1 immunohistochemical assessemnt of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 2005;58(2):202-6. Go to original source... Go to PubMed...
  49. Tanigawa N, Kanazawa T, Satomura K, Hikasa Y, Hashida M, Muranishi S, Sezaki H. Experimental study on lymphatic vascular changes in the development of cancer. Lymphology 1981;14(4):149-54. Go to PubMed...
  50. Williams CSM, Leek RD, Robson AM, Banerji S, Prevo R, Harris AL, Jackson DG. Absence of lymphangiogensis and intratumoral lymph vessels in human metastasic breast cancer. J Pathol 2003;200(2):195-206. Go to original source... Go to PubMed...
  51. Agarwal B, Saxena R, Morimiya A, Mehrotra S, Badve S. Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol 2005;29(11):1449-55. Go to original source... Go to PubMed...
  52. Baek SK, Jung KY, Lee SH, Woo JS, Kwon SY, Chung EJ, Kim TH, Chae YS.Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squmaous cell carcinoma. Laryngoscope 2009;119(7):1325-30. Go to original source... Go to PubMed...
  53. Franchi A, Gallo O, Massi D, Baroni G, Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma. A morphometric study with clinical correlations. Cancer 2004;101(5):973-8. Go to original source... Go to PubMed...
  54. Maula SM, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamäki R. Intratumoral lymphatics are essential for the metastatis spread and prognosis in squamous cell carcinoma of the head and neck region. Cancer Res 2003;63(8):1920-6. Go to PubMed...
  55. Muñoz-Guerra MF, Marazuela EG, Martín-Villar E, Quintanilla M, Gamallo C. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. Cancer 2004;100(3):553-60. Go to original source... Go to PubMed...
  56. Maby-El Hajjami H, Petrova TV. Developmental and pathological lymphangiogenesis: from models to human disease. Histochem Cell Biol 2008;130(6):1063-78. Go to original source... Go to PubMed...
  57. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 2000;60(16):4324-7. Go to PubMed...
  58. Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK. Pathology: Cancer cells compress intratumour vessels. Nature 2004;427(6976):695. Go to original source... Go to PubMed...
  59. Skobe M, Detmar M. Structure, function and molecular control of the skin lymphatic system. J Investig Dermatol Symp Proc 2000;5(1):14-9. Go to original source... Go to PubMed...
  60. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest 2005;115(9):2316-19. Go to original source... Go to PubMed...
  61. Björndahl MA, Cao R, Burton JB, Brakenhielm E, Religa P, Galter D, Wu L, Cao Y. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 2005;65(20):9261-8. Go to original source... Go to PubMed...
  62. Honda K, Kashima K, Daa T, Yokoyama S, Nakayama I. Clonal analysis of the epithelial component of Warthin's tumor. Hum Pathol 2000;31(11):1377-80. Go to original source... Go to PubMed...
  63. Rabia AB, Ebru LS, Tuba K, Didar G, Gulhan O, Cengiz O. Warthin's tumor: An unknown pathogenesis: A neoplasm or a reactive hyperplasia? Indian J Pathol Microbiol 2015;58(1):7-11. Go to original source... Go to PubMed...